JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (2): 96-98.doi: 10.6040/j.issn.1673-3770.0.2017.033

Previous Articles     Next Articles

Clinical observation on the treatment of CSME and NCSME by intravitreal injection of ranibizumab.

  

  1. Taishan Medical University, Taian 271000, Shandong, China
  • Received:2017-01-19 Online:2017-04-16 Published:2017-04-16

PDF (PC)

550

Abstract: Objective To explore the clinical efficacy of clinically significant macular edema(CSME)and non-clinically significant macular edema(NCSME)treated with Ranibizumab intravitreal injection. Methods A total of 77 BRVO-ME cases were divided into 2 groups: CSME group(n=51)and NCSME group(n=26). The two groups received Ranibizumab intravitreal injection. Best corrected visual acuity(BCVA)and highest thickness of macular edema of the two groups were observed. Results One months after treatment, BCVA of the two groups were improved(P<0.05). No significant difference between two groups was found in the highest thickness of macular edema(P>0.05). Conclusion Ranibizumab intravitreal injection can improve visual acuity and reduce the highest thickness of macular edema in patients with CSME and NCSME. The highest thickness of macular edema can not completely reflect the visual acuity.

Key words: Best corrected visual acuity, Highest thickness, Diabetic macular edema, Ranibizumab

CLC Number: 

  • R774
[1] 中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014)[J]. 中华眼科杂志,2014,50(11):851-865.
[2] Klein R, Knudtson MD, Lee KE, et al. The wisconsin epidemiologic study of diabetic retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes[J]. Ophthalmology, 2009, 116(3):497-503.
[3] LHeveder R, Nolan T. International diabetes federation[J]. Diabetes Research & Clinical Practice, 2013, 101(3):349-351.
[4] 金慧昳,刘海芸,刘堃,等. 糖尿病黄斑水肿患者黄斑区形态与视功能的关系[J]. 中华医学杂志, 2013, 93(7):524-527. JIN Huiyi, LIU Haiyun, LIU Kun, et al. Relationship between macular morphology and visual function in diabetic macular edema[J]. Natl Med J Chin, 2013, 93(7):524-527.
[5] 董蒙,陈松. 雷珠单抗治疗糖尿病黄斑水肿研究进展[J]. 中国实用眼科杂志,2014,32(6):686-689.
[6] Azad SV, Salman A, Mahajan D, et al. Comparative evaluation between Ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion[J]. Mid East Afr J Ophthalmol, 2014, 21(4):296-301.
[7] Good TJ, Kimura AE, Mandava N, et al. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents[J]. Br J Ophthalmol, 2011, 95(8):1111-1114.
[8] Lyall DAM, Tey A, Foot B, et al. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors and outcomes[J]. Eye, 2012, 26(12):1517-1526.
[9] Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature[J]. Eye, 2013, 27(7):787-94.
[10] Mori F, Hikichi T, Takahashi J, et al. Dysfunction of active transport of blood-retinal barrier in patients with clinically significant macular edema in type 2 diabetes[J]. Diabetes Care, 2002, 25(7):1248-1249.
[11] Emanuele N, Moritz T, Klein R, et al. Ethnicity,race,and clinically significant macular edema in the Veterans Affairs Diabetes Trial(VADT)[J]. Diab Res Clin Pract, 2009, 86(2):104-110.
[12] Jew OM, Peyman M, Chen TC, et al. Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes[J]. Int J Ophthalmol, 2012, 5(4):499-504.
[13] Ribeiro L, Nunes S, Cunhavaz J. Microaneurysm turnover in the macula is a biomarker for development of clinically significant macular edema in type 2 diabetes[J]. Current Biomarker Findings, 2013, 3:11-15.
[14] Holekamp NM, Liu Y, Yeh WS, et al. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration[J]. Am J Ophthalmol, 2014, 157(4):825-833.
[15] Campochiaro PA, Aiello LP, Rosenfeld PJ. Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside[J]. Ophthalmology, 2016, 123(10):S78-S88.
[16] Kiss CG, Barisani-Asenbauer T, Maca S, et al. Reading performance of patients with uveitis-associated cystoid macular edema[J]. Am J Ophthalmol, 2006, 142(142):620-624.
[17] Network DRC. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema[J]. Ophthalmology, 2007, 114(3):525-536.
[18] 韩月圣, 魏文斌. Ranibizumab玻璃体腔注射后糖尿病黄斑水肿患者中心视网膜厚度相对变化与视力预后的关系[J].中华实验眼科杂志,2016,34(1):78-84. HAN Yuesheng, WEI Wenbin. The relationship between central retinal thickness relative change and visual prognosis in diabetic macular edema patients following intravitreal injection of ranibizumab[J]. Chin J Exper Ophthalmol, 2016, 34(1):78-84.
[19] Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study[J]. Ophthalmology, 2009, 116(3):461-461.
[20] Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE[J]. Ophthalmology, 2012, 119(4):789-801.
[21] 刘玉华,高玲. 糖尿病视网膜病变治疗研究现状、问题与展望[J]. 中华眼底病杂志,2016,32(2):206-210. LIU Yuhua, GAO Ling. The status, problem and progress of diabetic retinopathy treatment[J]. Chin J Ocular Fundus Dis, 2016, 32(2):206-210.
[22] 许迅,郑颖. 重视对糖尿病黄斑水肿的治疗[J].中华眼底病杂志,2016,32(2):119-121. XU Xun, ZHENG Ying. Focusing on the treatment of diabetic macular edema[J]. Chinese Journal of Ocular Fundus Diseases, 2016, 32(2):119-121.
[23] 汪枫桦,张鹏飞,孙晓东. 抗血管内皮生长因子治疗不应忽视激光的作用[J]. 中华眼科杂志,2015,51(12):885-887. WANG Fenghua, ZHANG Pengfei, SUN Xiaodong. The role of laser photocoagulation in the anti-vascular endothelial growth factor therapy era[J]. Chin J Ophthalmol, 2015, 51(12):885-887.
[1] ZHOU Xueyi, LI Yiming, WANG Meiju, ZHANG Yuanyuan, ZHANG Lizhuo. The application of 25-gauge minimally invasive vitreoretinal surgery combined with intravitreal ranibizumab injections in the treatment of proliferative diabetic retinopathy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 87-89.
[2] . Clinical observation on the treatment of BRVO-ME by the combination of laser therapy with Ranibizumab intravitreal injection. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 110-113.
[3] ZHAO Lu, XIE Guoli, WANG Yanling. Changes of ocular hemodynamics after intravitreal ranibizumab injection in patients with wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(4): 101-104.
[4] SHAO Na, ZHANG Han. Variation of visual acuity and fundus in type 2 diabetic patients after phacoemulsification surgery. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 83-87.
[5] CHAI Xuerong, ZHANG Shixi, TAO Yu, SHEN Jiaquan. Effect of intravitreal ranibizumab injection combined with trabelectomy and panretinal photocoagulation for neovascular glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(3): 72-75.
[6] ZI Yu-meng1, WANG Yu2, FAN Chuan-feng2, SHU Xiang-wen2, WU Chang-long2. Intravitreal injection of Ranibizumab for idiopathic choroidal neovascularization lesion in two courses [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 63-66.
[7] ZHANG Ai-hui1， ZHU Ling1, ZHANG Jin-zhi1， ZHANG Wei2. Correlation between cataract phacoemulsification with intraocular lens implantation and age-related macular degeneration [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 77-83.
[8] XIE Li, WEI wei. Treatment progress of diabetic macular edema [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 81-85.
[9] WANG Yong-bo， SHI An-na， SHI Xun， JIN Yu， LIU Wei-feng. Relationship between photoreceptor cell layer and best corrected visual acuity (BCVA) in patients with retinal vein occlusion [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(1): 78-80.
[10]

LU Ai-dong,LIU Xiao-ling,GAO Jie,CHEN Fang,LIANG Zhong-qi

. Triamcinolone acetonide combined with micro-pulse diode laser in treatment of diabetic macular edema [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(4): 366-368 .
[11] LU Ai-dong,CHEN Fang,LIANG Zhong-qi . Effects of triamcinolone acetonide treatment for diabetic macular edema [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(1): 17-18 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd